OR13-02 Treatment with Zoledronic Acid Subsequent to...

Journal of the Endocrine Society 2020 / 05 Vol. 4; Iss. Supplement

OR13-02 Treatment with Zoledronic Acid Subsequent to Denosumab Cannot Fully Prevent Bone Loss

Sølling, Anne Sophie K, Harsløf, Torben, Langdahl, Bente Lomholt
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
4
Journal:
Journal of the Endocrine Society
DOI:
10.1210/jendso/bvaa046.1217
Date:
May, 2020
File:
PDF, 110 KB
2020
Conversion to is in progress
Conversion to is failed